Dichoptic Treatment for Lazy Eye
(ATS23 Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests two treatments for children aged 4 to 7 with lazy eye (amblyopia). One group will watch special movies using a headset for one hour a day, six days a week, as part of the dichoptic treatment (also known as Luminopia or Dichoptic Therapy). The other group will wear a patch over the stronger eye for two hours a day, seven days a week. The trial aims to determine if watching movies with the headset is as effective as the traditional patching method. Children with lazy eye due to crossed eyes or differences in eye prescription, who are willing to try either approach, might be a good fit. As a Phase 3 trial, this study represents the final step before FDA approval, offering participants a chance to contribute to a potentially groundbreaking treatment for lazy eye.
Will I have to stop taking my current medications?
The trial requires that participants stop using cycloplegic eyedrops (like atropine) at least 2 weeks before enrolling. Other treatments are allowed up to enrollment but must be discontinued once the trial begins.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that dichoptic treatment for amblyopia, or lazy eye, is generally safe for children. This therapy involves watching special movies using a headset and is usually well-tolerated. Studies comparing different treatments found that dichoptic therapy not only improves vision but is also safe. Some children might feel slight discomfort wearing the headset, but serious side effects are rare. Overall, this treatment is considered a safe way to help children with lazy eye see better.12345
Why do researchers think this study treatment might be promising for lazy eye?
Researchers are excited about dichoptic treatment for lazy eye, also known as amblyopia, because it offers a fresh approach compared to traditional methods like eye patching or atropine drops. This treatment is unique as it involves watching specially designed movies or shows using a Luminopia headset, which presents different images to each eye, encouraging the brain to improve visual processing and coordination. Unlike patching, which can be uncomfortable and socially awkward, the Luminopia headset provides a more engaging and enjoyable experience for children. This innovative method could make treatment adherence better and potentially lead to faster and more effective results in improving vision.
What evidence suggests that dichoptic treatment might be an effective treatment for lazy eye?
This trial will compare dichoptic treatment with traditional patching for lazy eye. Studies have shown that dichoptic treatment, such as watching movies or shows with a special headset, can improve vision in people with amblyopia, commonly known as lazy eye. This method uses different images for each eye to help the brain improve how the eyes work together. Research indicates that this treatment can be as effective as the traditional method of covering one eye to strengthen the weaker one. Specifically, a study found that a digital device using both eyes was as effective as patching for improving vision. This suggests that dichoptic treatment is a promising option for treating lazy eye in children.13467
Who Is on the Research Team?
Kammi Gunton, MD
Principal Investigator
Wills Eye Hospital
Aparna Raghuram, OD, PhD
Principal Investigator
Boston Children's Hospital/ Harvard Medical School
Robert Henderson, MS
Principal Investigator
Jaeb Center for Health Research
Are You a Good Fit for This Trial?
This trial is for children aged 4 to 7 with lazy eye (amblyopia) who have a small misalignment of the eyes or a history of strabismus, a significant difference in vision between eyes, and normal vision in the non-affected eye. Children with severe eye deviations or other conditions that could interfere with treatment are not eligible.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either dichoptic treatment with the Luminopia headset or patching treatment for amblyopia
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Dichoptic Treatment
Dichoptic Treatment is already approved in United States for the following indications:
- Amblyopia (lazy eye) in children aged 4-7 years
Find a Clinic Near You
Who Is Running the Clinical Trial?
Jaeb Center for Health Research
Lead Sponsor
National Eye Institute (NEI)
Collaborator
Pediatric Eye Disease Investigator Group
Collaborator